Replies to post #2013 on Nutra Pharma Corp (NPHC)

[mikeyk]

How can you verify the deal, how about just reading the company PR about it, it clearly states marketing and distribution in the US market:

8/26/2009

Nutra Pharma Announces Licensing Agreement with XenaCare Holdings to Market & Distribute Cobroxin, a Treatment for Chronic Pain

Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it has successfully completed a licensing agreement that grants XenaCare Holdings (OTCBB:XCHO) ongoing exclusive United States marketing and distribution rights for Cobroxin in return for meeting specific minimum performance requirements.